[SIME] QoQ Annualized Quarter Result on 31-Mar-2017 [#3]

Announcement Date
31-May-2017
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2017
Quarter
31-Mar-2017 [#3]
Profit Trend
QoQ- 5.93%
YoY- 46.78%
View:
Show?
Annualized Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 33,918,000 32,576,000 31,087,000 30,516,000 30,040,000 27,736,000 29,452,000 9.84%
PBT 1,028,000 1,504,000 1,007,000 1,212,000 1,198,000 1,248,000 1,046,000 -1.14%
Tax 2,448,000 4,072,000 1,674,000 1,529,333 1,378,000 1,068,000 1,566,000 34.58%
NP 3,476,000 5,576,000 2,681,000 2,741,333 2,576,000 2,316,000 2,612,000 20.92%
-
NP to SH 3,242,000 5,264,000 2,438,000 2,489,333 2,350,000 2,088,000 2,422,000 21.39%
-
Tax Rate -238.13% -270.74% -166.24% -126.18% -115.03% -85.58% -149.71% -
Total Cost 30,442,000 27,000,000 28,406,000 27,774,666 27,464,000 25,420,000 26,840,000 8.73%
-
Net Worth 14,554,140 38,561,670 37,337,488 37,269,480 36,072,640 31,642,857 32,091,767 -40.88%
Dividend
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Div 272,040 - 1,564,230 544,080 795,720 - 1,692,339 -70.33%
Div Payout % 8.39% - 64.16% 21.86% 33.86% - 69.87% -
Equity
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Net Worth 14,554,140 38,561,670 37,337,488 37,269,480 36,072,640 31,642,857 32,091,767 -40.88%
NOSH 6,800,839 6,800,839 6,800,839 6,800,839 6,800,839 6,328,571 6,267,923 5.57%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 10.25% 17.12% 8.62% 8.98% 8.58% 8.35% 8.87% -
ROE 22.28% 13.65% 6.53% 6.68% 6.51% 6.60% 7.55% -
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 498.72 478.99 457.09 448.70 453.02 438.27 469.88 4.03%
EPS 47.60 77.20 36.70 37.73 36.20 32.80 38.60 14.95%
DPS 4.00 0.00 23.00 8.00 12.00 0.00 27.00 -71.90%
NAPS 2.14 5.67 5.49 5.48 5.44 5.00 5.12 -44.00%
Adjusted Per Share Value based on latest NOSH - 6,800,839
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 497.90 478.20 456.35 447.96 440.98 407.15 432.34 9.84%
EPS 47.59 77.27 35.79 36.54 34.50 30.65 35.55 21.40%
DPS 3.99 0.00 22.96 7.99 11.68 0.00 24.84 -70.35%
NAPS 2.1365 5.6607 5.481 5.471 5.2953 4.6451 4.711 -40.88%
Price Multiplier on Financial Quarter End Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 -
Price 2.21 9.02 9.50 9.28 8.10 7.65 7.59 -
P/RPS 0.44 1.88 2.08 2.07 1.79 1.75 1.62 -57.96%
P/EPS 4.64 11.65 26.50 25.35 22.86 23.19 19.64 -61.68%
EY 21.57 8.58 3.77 3.94 4.38 4.31 5.09 161.18%
DY 1.81 0.00 2.42 0.86 1.48 0.00 3.56 -36.21%
P/NAPS 1.03 1.59 1.73 1.69 1.49 1.53 1.48 -21.41%
Price Multiplier on Announcement Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 22/02/18 16/11/17 25/08/17 31/05/17 27/02/17 25/11/16 23/08/16 -
Price 2.75 9.00 9.13 9.32 9.07 8.10 7.80 -
P/RPS 0.55 1.88 2.00 2.08 2.00 1.85 1.66 -52.02%
P/EPS 5.77 11.63 25.47 25.46 25.59 24.55 20.19 -56.51%
EY 17.33 8.60 3.93 3.93 3.91 4.07 4.95 130.04%
DY 1.45 0.00 2.52 0.86 1.32 0.00 3.46 -43.91%
P/NAPS 1.29 1.59 1.66 1.70 1.67 1.62 1.52 -10.33%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment